| You are here: Home: BCU 7|2003: Rowan
T Chlebowski, MD, PhD: Select publications
Select publications
Publications discussed by Dr Chlebowski
Bertelli G et al. Intramuscular depot medroxyprogesterone
versus oral megestrol for the control of postmenopausal hot flashes
in breast cancer patients: A randomized study. Ann Oncol
2002;13(6):883-8. Abstract
Beral V; Million Women Study Collaborators. Breast
cancer and hormone-replacement therapy in the Million Women Study. Lancet
2003; 362:419-27.Abstract.
Boyd NF et al. Heritability of mammographic
density, a risk factor for breast cancer. N Engl J Med 2002;347(12):886-94.
Abstract
Chlebowski RT et al; WHI Investigators. Influence
of estrogen plus progestin on breast cancer and mammography in
healthy postmenopausal women: The Women's Health Initiative Randomized
Trial. JAMA 2003;289(24):3243-53. Abstract
Lagro-Janssen T et al. Breast cancer and
hormone-replacement therapy: Up to general practice to pick up
the pieces. Lancet 2003; 362:
419-27. Abstract.
Manson JE et al; Women's Health Initiative Investigators. Estrogen
plus progestin and the risk of coronary heart disease. N Engl J
Med 2003;349(6):523-34. Abstract
Naessen T et al. Serum lipid profile improved
by ultra-low doses of 17 beta-estradiol in elderly women. J Clin Endocrinol Metab
2001;86(6):2757-62. Abstract
Rossouw JE et al; Writing Group for the Women's Health Initiative
Investigators. Risks and benefits of estrogen
plus progestin in healthy postmenopausal women: Principal results
from the Women's Health Initiative randomized controlled trial. JAMA 2002;288(3):321-33.
Abstract
Shumaker SA et al; WHIMS Investigators. Estrogen
plus progestin and the incidence of dementia and mild cognitive
impairment in postmenopausal women: The Women's Health Initiative
Memory Study: A randomized controlled trial. JAMA2003;289(20):2651-62. Abstract
|
